The Impact of Treatment of Chronic Obstructive Pulmonary Disease (COPD) on Functional Status and Quality of Life of Patients

CHEST Journal ◽  
2012 ◽  
Vol 142 (4) ◽  
pp. 728A
Author(s):  
Drosos Tsavlis ◽  
Mamas Theodorou ◽  
Anna Tzoumaka ◽  
Hellie Lithoxopoulou ◽  
Panagiotis Minogiannis ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Functional Status ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
The Impact

scholarly journals The observational, cross sectional study to assess quality of life on patient suffering from chronic obstructive pulmonary disease in tertiary care hospital

2020 ◽  
Vol 9 (1) ◽  
pp. 162
Author(s):  
Kavita S. Joshi ◽  
Prasad R. Amrale ◽  
Sagar S. Ahire
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Well Being ◽  
Health Improvement ◽  
Chronic Obstructive ◽  
Care Hospital ◽  
Obstructive Pulmonary Disease ◽  
The Impact

Background: Chronic obstructive pulmonary disease (COPD) patients often present considerable individual medical burden in their symptoms, limitations, and well-being that complicate medical treatment. Quality of life (QOL) is an important aspect for measuring the impact of chronic diseases. HRQOL measurement facilitates the evaluation of efficacy of medical interventions and also the detection of groups at risk of psychological or behavioural problems.Methods: COPD patient attending the OPD/IPD are screened as per inclusion and exclusion criteria. After obtaining a written informed consent of eligible patient, they were enrolled in the study. QOL of patient is assessed based on a set of questionnaire i.e. COPD Assessment Test™ (CAT). The questionnaire was translated to Hindi and Marathi. Socio demographic variable like age, sex, education occupation and income are also collected. All 8 questions related to health-improvement and management of COPD. CAT scores were given to each question according to the level of impact.Results: In the total score of CAT we observed that there were 2.04% patients with very good QOL, 25.51% with good QOL, 61.22% with moderate QOL and 11.22% with poor QOL.Conclusions: We conclude that the quality of life is moderate in larger number of patient’s population. The most affected domain was the patient’s energy level. The patients enrolled had COPD from long period of time which might have affected their answer because they have been habitual with the difficulties arising from COPD.

scholarly journals Quality of life in patients with COPD, depending on the presence of comorbidities

2020 ◽  
Vol 19 (4) ◽  
pp. 244-250
Author(s):  
Ewelina Dziedzic ◽  
Bożena Zboina ◽  
Krzysztof Cudzik ◽  
Renata Stępień
Keyword(s):  
Quality Of Life ◽  
Myocardial Infarction ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Health Condition ◽  
Survey Method ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
The Impact

AbstractIntroduction. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the world among chronic diseases. The article discusses the relationship between the quality of life of patients with COPD and the presence of diseases associated mainly with hypertension, diabetes and hyperlipidemia. The examination includes subjective and holistic assessment of the patient’s health condition, which allows to notice any disorders and deficits in the functioning of patients with this disease.Aim. The aim of the study was to determine the quality of life of patients with chronic obstructive pulmonary disease depending on the comorbidities.Material and methods. The study included 319 COPD patients treated in the Lung Diseases Clinic with chronic obstructive pulmonary disease. The study was conducted using a diagnostic survey method and analyzing medical records. The research tool assessing patients quality of life was the SGRQ questionnaire (Saint George Hospital Questionaire).Results. Respondents who had a myocardial infarction had a slightly lower quality of life in the “Impact on life subscale” (p=0.047). It was noted that patients with hypertension had a lower quality of life in the domain of “Activity” (p<0.05) and “Impact on life” (p<0.001). However, with hyperlipidemia, a lower quality of life was noticeable in the “Symptoms” (p<0.001) and “Impact on life” subscale (p=0.002).Conclusions. Exacerbation of symptoms in the course of chronic obstructive pulmonary disease, a history of myocardial infarction, hypertension and hyperlipidemia are significantly related to the decreased quality of life of patients. Prevention of these civilization diseases can prevent deterioration of the quality of life of patients.

Early bronchodilatory response to the first dose of indacaterol/glycopyrronium as an additional individual predictor of their effectiveness in the treatment of chronic obstructive pulmonary disease

2020 ◽  
Vol 22 (4) ◽  
pp. 17-22
Author(s):  
N. V. Sharova ◽  
S. L. Grishaev ◽  
D. V. Cherkashin ◽  
S. V. Efimov ◽  
M. A. Kharitonov ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Clinical Signs ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Obstructive Pulmonary Disease ◽  
Long Acting ◽  
The Impact

The effectiveness of the early bronchodilatory response of the first dose of a fixed double combination of long-acting bronchodilators of various classes indacaterol/glycopyrronium and long-acting anticholinergics glycopyrronium and Tiotropium in patients suffering from stable chronic obstructive pulmonary disease is compared. It was found that in all patients included in the study and suffering from chronic obstructive pulmonary disease, changes in functional respiratory indicators were accompanied by positive and comparable dynamics of clinical signs: a decrease in the severity of shortness of breath, the impact of the disease on the quality of life and increased tolerance to physical activity. It was found that the combination of indacaterol/glycopyrronium provides rapid, pronounced and prolonged bronchodilation in patients suffering from chronic obstructive pulmonary disease compared to the separate use of glycopyrronium and Tiotropium. Consistent use of glycopyrronium and salbutamol leads to maximum bronchodilation, which makes it advisable to separate the use of prolonged bronchodilators when initiating therapy for chronic obstructive pulmonary disease. Therefore, there is a clinical feasibility of taking not only fixed combinations of bronchodilators of different classes, but also their consistent use. The results of an early bronchodilatory response to the first dose of indacaterol/glycopyrronium can be used as an additional individual predictor of their effectiveness in the treatment of chronic obstructive pulmonary disease.

scholarly journals Predicting Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: The Impact of Age

Respiration ◽  
2016 ◽  
Vol 92 (4) ◽  
pp. 229-234 ◽  
Author(s):  
Alexandru Corlateanu ◽  
Victor Botnaru ◽  
Serghei Covantev ◽  
Silvia Dumitru ◽  
Nikolaos Siafakas
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Health Related Quality ◽  
Obstructive Pulmonary Disease ◽  
Related Quality ◽  
Health Related ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document